Colitis, Ulcerative: all 1,530 studies

Page 13 of 16. Open to participants first (407), then studies with results posted, then the rest; newest registration first within each.

• Combination Corticosteroids+5-aminosalicylic Acids Compared to Corticosteroids Alone (for Ulcerative Colitis).CompletedNCT02665845Phase 3
• An Open Label Phase 4 Study to Evaluate Efficacy of Early Versus Late Use of Vedolizumab in Ulcerative ColitisCompletedNCT02646657Phase 4
• Predictive Factors of Endoscopic Mucosal Healing in Quiescent Ulcerative ColitisCompletedNCT02640391
• Home basEd faecaL calProtectin Measurements Predicting Adalimumab Induction DestinyCompletedNCT02634060Not applicable
• Initial Experience With a Novel Single-Balloon Enteroscopy System in Children With IBDStatus unknownNCT02629211Not applicable
• Multispectral Optoacoustic Tomography (MSOT) for the Evaluation of Disease Activity in Inflammatory Bowel Diseases (IBD)CompletedNCT02622139Not applicable
• Biomarkers in Inflammatory Bowel DiseasesCompletedNCT02612103
• Comparison of PillCamCOLON (C2) Capsule and Standard Endoscopy for the Evaluation of Patients With Ulcerative ColitisCompletedNCT02610569Not applicable
• Trial of Antimicrobials Versus Placebo in Addition to Fecal Transplant Therapy in Ulcerative ColitisCompletedNCT02606032Phase 2
• Effectiveness of Cortiment® in Patients With Ulcerative ColitisCompletedNCT02586259
• Azathioprine Based on Endoscopy After Clinical Remission in Moderate to Severe Ulcerative ColitisTerminatedNCT02579733Phase 4
• Patient Centered Algorithms to Optimize the Inpatient Experience and Treatment of Ulcerative ColitisCompletedNCT02569333Not applicable
• Budesonide 9 mg Capsules in Active UCCompletedNCT02550418Phase 2
• A Study Evaluating the Impact of an Educational Program (EDU-MICI) on Patients With Inflammatory Bowel DiseaseCompletedNCT02550158Not applicable
• Aminosalicylic Acid Withdrawal Study in Long Standing Inactive Ulcerative ColitisCompletedNCT02537210Not applicable
• Fecal Microbiota Transplantation (FMT) in the Management of Ulcerative Colitis (UC)CompletedNCT02516384Phase 1
• Medico-economic Evaluation of the Therapeutic Drug Monitoring of Anti-TNF-α Agents in Inflammatory Bowel DiseasesCompletedNCT02508012Not applicable
• Impact of Adalimumab on Patient-reported Outcomes in Ulcerative ColitisCompletedNCT02506179
• Study of Anti-glycan Antibodies Stability in Saint-Etienne IBD CohortCompletedNCT02502552
• Interest of Propionibacterium Freudenreichii for the Treatment of Mild to Moderate Ulcerative ColitisTerminatedNCT02488954Not applicable
• Pediatric FEcal Microbiota Transplant for Ulcerative ColitisCompletedNCT02487238Phase 1
• Diet Treatment of Patients With Ulcerative Colitis in RemissionCompletedNCT02469220Not applicable
• The Utility of Second Generation Colon Capsule Endoscopy in Ulcerative ColitisCompletedNCT02469103Not applicable
• Therapeutic Modulation of the Intestinal Creatine Kinase System in Inflammatory Bowel Disease (IBD)WithdrawnNCT02463305Early Phase 1
• Study for Safety and Tolerability of TOP1288 Administered Rectally in Healthy and Ulcerative Colitis SubjectsCompletedNCT02463045Phase 1
• "Efficacy and Safety of Infliximab-biosimilar (Inflectra) Compared to Infliximab-innovator (Remicade) in Patients With Inflammatory Bowel Disease in Remission: the SIMILAR Trial"Status unknownNCT02452151Phase 4
• Remote Ischemic Conditioning in Patients With Ulcerative ColitisCompletedNCT02445365Not applicable
• Evaluating Safety and Efficacy of Herbal Treatment in Ulcerative ColitisCompletedNCT02442960Phase 1
• Human Umbilical-Cord-Derived Mesenchymal Stem Cell Therapy in Active Ulcerative ColitisStatus unknownNCT02442037Phase 1/2
• Assessment of CMV-specific ELISPOT Assay for Predicting CMV Colitis in Patient With Ulcerative ColitisCompletedNCT02439372
• The Study of Efficacy and Mechanism in Fecal Microbiota Transplantation in the Treatment of Ulcerative ColitisStatus unknownNCT02435160Phase 2/3
• Safety and Efficacy of QBECO in Moderate to Severe Ulcerative ColitisCompletedNCT02426372Phase 2
• Intensive Treatment to Reach the Target With Golimumab in ulcErative coliTis - In-TARGETCompletedNCT02425865Phase 4
• The Impact of Anti-TNF Exposure on Vedolizumab EffectivenessCompletedNCT02423512
• Threonine Requirement in IBD Adults and Healthy Adult ControlsCompletedNCT02423460Not applicable
• Golimumab in Steroid-dependent Ulcerative Colitis: Induction and Maintenance of Clinical and Endoscopic RemissionStatus unknownNCT02412085Phase 4
• Immune Modulation From Trichuris TrichiuraCompletedNCT02399683
• Fecal Microbiota Transplant in the Treatment of Ulcerative ColitisStatus unknownNCT02390726Early Phase 1
• SSAT 054: Non Genetic Factors in the Pathogenesis of IBD in TwinsStatus unknownNCT02383953
• An Efficacy and Safety Study of PENTASA in Chinese Patients With Left-sided Active Ulcerative Colitis Followed by a 24-Week Open-Label Extension PhaseCompletedNCT02368717Phase 3
• The Effect of the Multispecies Probiotic Ecologic 825 Versus Placebo in Ulcerative Colitis PatientsSuspendedNCT02361957Not applicable
• Decentralized Dietary UC Pilot TrialStatus unknownNCT02357537Not applicable
• Use of a Novel Diet (UC DIET) for Treatment of Mild to Moderate Active Pediatric Ulcerative ColitisCompletedNCT02345733Phase 4
• Efficacy and Safety of GLPG1205 in Subjects With Active Ulcerative ColitisCompletedNCT02337608Phase 2
• Standardized Fecal Microbiota Transplantation for Inflammatory Bowel DiseaseStatus unknownNCT02335281Phase 2
• Trial on Impact of HealthPROMISE Mobile App on Inflammatory Bowel Disease Care and Quality of LifeCompletedNCT02322307Not applicable
• Telephone Consultation as a Substitute for Routine Out-patient Face-to-face Consultation for Children With Inflammatory Bowel DiseaseCompletedNCT02319798Not applicable
• TP0502-B-Pharmaco-Scintigraphic-StudyCompletedNCT02306798Phase 1
• TP0502-Pharmaco-Scintigraphic-Study and AmendmentCompletedNCT02306785Phase 1
• TP0501 - Pharmaco-Scintigraphic-StudyCompletedNCT02306772Phase 1
• Study of Inflammatory Markers (VNN1) in Crohn Disease and Ulcerative Colitis.Status unknownNCT02304666Not applicable
• The Effect of Therapeutic Fecal Transplant on the Gut Microbiome in Children With Ulcerative ColitisActive, not recruitingNCT02291523Phase 1
• Phosphatidylcholine (LT-02) vs. Placebo vs. Mesalamine for Maintenance of Remission in Ulcerative Colitis (PROTECT-2)CompletedNCT02280629Phase 3
• Study of the Pharmacokinetics of Golimumab in Moderate to Severe Ulcerative ColitisStatus unknownNCT02277470
• Curcumin in Pediatric Ulcerative ColitisWithdrawnNCT02277223Phase 3
• Dysmenorrhea in Women With Crohn's Disease and Ulcerative ColitisCompletedNCT02274714
• Study of Freeze-dried Black Raspberry in Maintenance of Ulcerative ColitisCompletedNCT02267694Phase 1
• Healthy Approach to Physical and Psychological Problems in Youngsters With IBD (HAPPY-IBD).CompletedNCT02265588Not applicable
• Induction and Maintenance of Remission With Pentasa as Ulcerative Colitis TreatmentCompletedNCT02261636
• Efficacy/Safety Pilot Study to Investigate Iberogast N's Efficacy in Mild to Moderate Colitis Ulcerosa PatientsTerminatedNCT02246686Phase 2
• Study of Clinical Course of Newly Diagnosed Moderate to Severe Ulcerative Colitis in KoreaCompletedNCT02229344
• Fecal Microbiota Transplantation (FMT) in the Management of Active Ulcerative ColitisCompletedNCT02227342Phase 1/2
• Use of the Ulcerative Colitis Diet for Induction of RemissionTerminatedNCT02217722Not applicable
• Treatment With the Specific Carbohydrate Diet for Children With Active Crohns Disease and Ulcerative ColitisCompletedNCT02213835Not applicable
• Absolute Bioavailability, Safety, and Tolerability of Subcutaneous GS-5745 in Healthy AdultsCompletedNCT02209987Phase 1
• Flaxseed Lignan-Enriched Complex (FLC) for the Treatment of Patients With Ulcerative Colitis (UC): A Pilot AssessmentWithdrawnNCT02201758Not applicable
• Physiological Intermolecular Modification Spectroscopy (PIMS) in Ulcerative Colitis With GolimumabStatus unknownNCT02186886Phase 4
• Thermography in Surveillance of Ulcerative ColitisCompletedNCT02149043
• The NOR-SWITCH StudyCompletedNCT02148640Phase 4
• Hyperbaric Oxygen for Ulcerative ColitisTerminatedNCT02144350Phase 2/3
• Effects of WB-EMS in Ulcerative Colitis PatientsWithdrawnNCT02144129Not applicable
• Phosphatidylcholine (LT-02) for Induction of Remission in Ulcerative ColitisTerminatedNCT02142725Phase 3
• High Definition Versus Chromoendoscopy for Dysplasia Detection in Ulcerative Colitis (UC)CompletedNCT02138318Not applicable
• IBDSL Biobank Project. Molecular Markers for Diagnosis and Therapy Response in IBD.Status unknownNCT02130349
• Efficacy, Pharmacokinetics, Tolerability, Safety of SB012 Intrarectally Applied in Active Ulcerative Colitis PatientsCompletedNCT02129439Phase 1/2
• Improving Knowledge of Medication in Ulcerative Colitis With an Iphone ApplicationCompletedNCT02120391Not applicable
• Scintigraphic Evaluation of IPAA Function in Patients With Ulcerative ColitisCompletedNCT02110862
• Personalized "Alberta" Diet for Prevention of Relapse in Ulcerative ColitisCompletedNCT02093780Not applicable
• Oligofructose-enriched Inulin for the Treatment of Mild to Moderate Active Ulcerative ColitisCompletedNCT02093767Not applicable
• A Blood and Tissue Sample Collection Study of Patients Who Have Inflammatory Bowel Disease, Who Have Been Treated With Adalimumab and Who Developed Hepatosplenic T-Cell LymphomaWithdrawnNCT02087878
• Improving OutcoMes in the Pediatric to Adult Care Transition in Inflammatory Bowel DiseaseCompletedNCT02085083Not applicable
• Amino Acids in Ileal Pouch-anal Anastomosis for Ulcerative ColitisStatus unknownNCT02084550Not applicable
• Moxibustion for Mild and Moderate Ulcerative ColitisCompletedNCT02084186Not applicable
• Effects of Eicosapentaenoic Acid on Subjects at High Risk for Colorectal CancerCompletedNCT02069561Not applicable
• A Pilot and Feasibility Study of Fecal Microbiota Transplantation for Ulcerative ColitisTerminatedNCT02058524Phase 1
• Study to Determine Risk Factors for Post-operative Infection in Inflammatory Bowel DiseaseCompletedNCT02054533
• Utilization of NBi in Assessing Luminal INflammaion in IBD (UNBLIND)Status unknownNCT02049775Not applicable
• Randomized-controlled Trial of Yoga for Ulcerative ColitisCompletedNCT02043600Not applicable
• Manipulating the Microbiome in IBD by Antibiotics and FMTCompletedNCT02033408Not applicable
• Evaluation of PillCam IBD Capsule Endoscopy System in Visualization of Lesions in the Colon Indicative of Ulcerative Colitis DiseaseCompletedNCT02025777Not applicable
• Evaluation of the Diagnostic Value of microRNAs for Inflammatory Bowel DiseasesCompletedNCT02020382Not applicable
• Safety and Tolerability Study of GSK2586184 in Patients With Moderate to Severely Active Ulcerative Colitis.TerminatedNCT02000453Phase 1
• Lipid Mediators in Colonic Biopsies as Biomarkers of Disease Activity of Inflammatory Bowel DiseasesCompletedNCT01990716Not applicable
• A Study to Evaluate the Accuracy of a Subset of the Length-109 Probe Set Panel (a Genetic Test) in Predicting Response to Golimumab in Participants With Moderately to Severely Active Ulcerative ColitisCompletedNCT01988961Phase 2
• Single Dose Escalation Trial to Evaluate the Safety, Tolerability Pharmacokinetics and Pharmacodynamics of GSK3050002CompletedNCT01984047Phase 1
• Early Serum Infliximab Levels in Severe Ulcerative Colitis.CompletedNCT01971814Phase 1
• Fecal Microbiota Transplantation in Patients With Ulcerative ColitisWithdrawnNCT01961492Not applicable
• Responsiveness of Endoscopic Evaluation in UCCompletedNCT01960439
• A Study of Safety and Effectiveness of JNJ-54781532 in Patients With Moderately to Severely Active Ulcerative ColitisCompletedNCT01959282Phase 2
• Fecal Microbiota Transplantation (FMT) for Treatment of Ulcerative Colitis in ChildrenCompletedNCT01947101Phase 1

← Colitis, Ulcerative overview